Business
Sangamo Therapeutics Announces Participation at the Jefferies Virtual Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at
About this update from Sangamo Therapeutics, Inc.
[{"type":"text","content":" BRISBANE, Calif.--(BUSINESS WIRE)--\nSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 4:00 p.m. ET.\n\n\nThe presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.\n\n\nAbout Sangamo Therapeutics \n\n\nSangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200529005093/en/\n\nInvestor Relations – Global\nMcDavid Stilwell\n510-970-6000, x219\[email protected]\n\nSource: Sangamo Therapeutics, Inc.","length":2556,"tagName":"div"}]